Loading…

AIF suppresses chemical stress-induced apoptosis and maintains the transformed state of tumor cells

Apoptosis‐inducing factor (AIF) exhibits reactive oxygen species (ROS)‐generating NADH oxidase activity of unknown significance, which is dispensable for apoptosis. We knocked out the aif gene in two human colon carcinoma cell lines that displayed lower mitochondrial complex I oxidoreductase activit...

Full description

Saved in:
Bibliographic Details
Published in:The EMBO journal 2005-08, Vol.24 (15), p.2815-2826
Main Authors: Urbano, Alexander, Lakshmanan, Umayal, Choo, Poh Heok, Kwan, Jair Chau, Ng, Poh Yong, Guo, Ke, Dhakshinamoorthy, Saravanakumar, Porter, Alan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Apoptosis‐inducing factor (AIF) exhibits reactive oxygen species (ROS)‐generating NADH oxidase activity of unknown significance, which is dispensable for apoptosis. We knocked out the aif gene in two human colon carcinoma cell lines that displayed lower mitochondrial complex I oxidoreductase activity and produced less ROS, but showed increased sensitivity to peroxide‐ or drug‐induced apoptosis. AIF knockout cells failed to form tumors in athymic mice or grow in soft agar. Only AIF with intact NADH oxidase activity restored complex I activity and anchorage‐independent growth of aif knockout cells, and induced aif ‐transfected mouse NIH3T3 cells to form foci. AIF knockdown in different carcinoma cell types resulted in lower superoxide levels, enhanced apoptosis sensitivity and loss of tumorigenicity. Antioxidants sensitized AIF‐expressing cells to apoptosis, but had no effect on tumorigenicity. In summary, AIF‐mediated resistance to chemical stress involves ROS and probably also mitochondrial complex I. AIF maintains the transformed state of colon cancer cells through its NADH oxidase activity, by mechanisms that involve complex I function. On both counts, AIF represents a novel type of cancer drug target.
ISSN:0261-4189
1460-2075
DOI:10.1038/sj.emboj.7600746